Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07286188 · ClinicalTrials.gov registry record · Phase 4
Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy
A Phase 4 study of Fibroids, Uterine and Fluid Deficit, sponsored by Northwestern University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07286188 is a Phase 4 study of Fibroids, Uterine and Fluid Deficit that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07286188, a Phase 4 study of Fibroids, Uterine and Fluid Deficit, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this double blinded randomized control trial is to evaluate the impact of misoprostol on fluid deficit during hysteroscopic myomectomies. The main questions it aims to answer are: Is there is difference in fluid deficit in patients who receive misoprostol vs placebo pre operatively for hysteroscopic myomectomies? Participants will be randomized to received 800 mcg of either rectal misoprostol prior to their hysteroscopic myomectomy or 4 tablets of placebo (ZEEBO) prior to their hysteroscopic myomectomy.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Misoprostol Tabets
Study Locations (1)
Illinois
- Northwestern - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-12-16 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07286188
The ClinicalTrials.gov registry entry for NCT07286188 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Fibroids, Uterine appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07286188 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT07286188 about?
NCT07286188 is a clinical study titled "Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy". The goal of this double blinded randomized control trial is to evaluate the impact of misoprostol on fluid deficit during hysteroscopic myomectomies. The main questions it aims to answer are: Is there is difference in fluid deficit in patients who receive misoprostol vs placebo pre operatively for ...
What is the current status of trial NCT07286188?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2025-12-16. Estimated completion is 2026-12.
What conditions does trial NCT07286188 study?
This clinical trial studies the following conditions: Fibroids, Uterine, Fluid Deficit, Hysteroscopy / Methods.
What interventions are being tested in trial NCT07286188?
The interventions under investigation include: Placebo (DRUG), Misoprostol Tabets (DRUG).
Who is sponsoring clinical trial NCT07286188?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07286188 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.